Document is current
Any future updates will be listed below
-
Authors
Mielke, Nina https://orcid.org/0000-0002-8951-9823
Ferrari, Damiano https://orcid.org/0009-0008-4395-7415
Barghouth, Muhammad Helmi https://orcid.org/0000-0002-5721-9367
Ebert, Natalie https://orcid.org/0000-0002-4463-3315
Kaiser, Janine https://orcid.org/0009-0000-4423-0148
Schaeffner, Elke https://orcid.org/0000-0002-7925-4577
-
Funding
Funding for this research was provided by:
DDnÄ – Institut für Disease Management e.V.
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 12 March 2026
Accepted: 28 May 2026
First Online: 12 June 2026
Declarations
:
: The study was approved by the ethics committee, Charité—Universitätsmedizin Berlin, Germany (EA2/009/08) and is in accordance with the 1964 Helsinki declaration and its later amendments. Written informed consent was obtained from all individual participants included in the study.
: The sponsors were not involved in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript.
: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. ES receives honoraria from the National Kidney Foundation and from AstraZeneca and Amgen. All others have nothing to disclose.
